The Latin America, Middle East and Africa C-Arms Market would witness market growth of 10.0% CAGR during the forecast period (2022-2028).
A range of diagnostic imaging as well as minimally invasive (MI) surgical procedures is performed using mobile C-Arm fluoroscopic X-ray equipment. In addition, they aid in visualizing procedures in the operating room (OR). Mini C-Arms, more compact imaging equipment utilized in sports medicine, orthopedic, and podiatric clinics, are classified as mobile C-Arms. Planning a hybrid OR requires using top-notch angiographic X-ray imaging technologies.
Due to the image quality being historically far greater than mobile C-Arms, traditionally large stationary angiography equipment was typically taken into account while designing these rooms. The capabilities of mobile C-Arms have, however, significantly increased over the past few years owing to developments in imaging software and detector technology. In order to avoid overheating during extended imaging, fixed systems also employ liquid cooling devices.
The need for C-Arm devices is growing due to the increased cancer incidence worldwide and the greater adoption of cancer therapies in emerging countries. It is evaluated that approximately 9.6 million cancer-related mortality occurred in 2018. Furthermore, the market is expected to grow as lifestyle illnesses become more prevalent and increase the likelihood of contracting noncommunicable diseases since C-Arms are crucial for risk assessment, early diagnosis, and effective treatment monitoring.
In 2011, the African governments reaffirmed their understanding of the growing health threat posed by noncommunicable diseases (NCDs), such as cancer. This understanding was reiterated in a document that was adopted subsequently called the Brazzaville Declaration on Noncommunicable Disease Prevention and Control in the WHO African Region. The signatories vowed to create prevention and control plans, improve their healthcare systems to lessen the burden of NCDs, find the funding necessary to fight these illnesses, and support the development of their national health information systems. As a result, these factors will probably increase the growth of the regional C-Arms market in the coming years.
The Brazil market dominated the LAMEA C-Arms Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $57.3 Million by 2028. The Argentina market is experiencing a CAGR of 10.6% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.7% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Diagnostic Centers and Specialty Clinics. Based on Type, the market is segmented into Mobile and Fixed. Based on Application, the market is segmented into Orthopedic & Trauma, Oncology, Cardiology, Gastroenterology, Neurology and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide C-Arms Market is Projected to reach USD 2.7 Billion by 2028, at a CAGR of 5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Canon, Inc. (Canon Medical Systems Corporation), Siemens Healthineers AG (Siemens AG), Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Fujifilm Holdings Corporation, Shimadzu Corporation, Hologic, Inc., Ziehm Imaging GmbH, Trivitron Healthcare Pvt. Ltd., and Nanjing Prelove Medical Equipment Co., Ltd.
By End User
By Type
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
